Policy Briefings

Section 232 Pharma Tariffs Expand Today: What Manufacturers Need to Know

MFN Deal Includes Revenue-Sharing With HHS on Overseas Sales

China Aims for 25% of Global First-in-Class Drugs by 2030

White House Secures $19.6B in Pharma Manufacturing Pledges

Trump Gives Generic Drugmakers Two Years to Reshore Before Tariffs Hit

Warren, Scott revive bill to map foreign control of US drug supply

Congress Proposes Federal Oversight for US-China Drug Licensing Deals

FDA Shakeup Continues: Høeg Fired, Davis Named Acting CDER Head

Trump Confirms Makary Exit; Diamantas Named Acting Chief

Regeneron Closes MFN Deal; Offers Gene Therapy Free

US Pharma Tariffs: 100% Headline Rate, Far Lower Real-World Impact

The European Biotech Act, Explained

Multistate Lawsuit Targets CDC Childhood Vaccine Rollback

Trump’s Tariffs Are Off — Or Are They? What Pharma Does Next

FDA and EMA Issue Joint AI Principles for Drug Development

EU Critical Medicines Act: What Manufacturing Leaders Must Prepare For

TrumpRx Launches: Will Direct-to-Consumer Platform Actually Lower Drug Costs?

J&J Strikes Drug Pricing Deal with Trump Administration

Nine Drugmakers Sign Trump MFN Deals in Single Day, Pledge $150B in US Manufacturing

US–UK Deal Sets Zero Tariffs, Raises UK Drug Value Thresholds

Trump Administration Launches Review of Global Drug Pricing Practises

Codis Begins Construction on PSD-4 Expansion to Increase Spray Drying Capacity

Lonza Expands Bioconjugation Manufacturing Capacity in Visp with Three New Suites

Experic Secures Irish GMP Certification for Clinical Trial Supply Facility

Piramal Pharma Solutions Wins Patient Centricity Award for Pithampur Dashboard

Gannet BioChem Partners With Re-Vana on cGMP Polymer Manufacturing

Adalvo Acquires Romiplostim Biosimilar Program From Enzene

ABIONYX Pharma Partners With AXPLORA to Complete CER-001 Manufacturing Chain

Octane Biotech and Currus Biologics Prepare CUR-001 for Phase 1 Clinical Trial

Made Scientific Partners With CARR Biosystems to Scale Cell Therapy Manufacturing

Recipharm Adds Sterile Cream and Ointment Line at Portugal Site

Zylidac Bio Partners With Prolific Machines to Scale Biologics Manufacturing

ProBio Completes NMPA Pre-Approval Inspection at Nanjing Biologics Facility

Ardena Invests in Compaction Simulator to Accelerate Tablet Development

Touchlight Appoints Will Downie as Interim CEO

ESTEVE CDMO Invests More Than $80 Million in New China Manufacturing Site

Viralgen Appoints Angela Ochoa Chico as CEO

S2N.Bio Partners with Cell Therapies for 2027 Alzheimer’s Clinical Trial

AtomVie Partners with Jubilant Radiopharma to Expand Clinical Trial Distribution

European CDMO Landscape 2025: Download the latest edition